Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies.
Huttner NA; Girod A; Perabo L; Edbauer D; Kleinschmidt JA; Büning H; Hallek M; Gene Therapy, 2003, vol. 10, issue 26, p 2139, ISSN 09697128. ISBN 09697128.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef